Patents by Inventor Kwang Hoe Kim

Kwang Hoe Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diagnostic method of liver cancer using ?-fetoprotein derived glycopeptides by mass spectrometry
    Patent number: 10697971
    Abstract: The present invention relates to a diagnosis method of liver cancer using mass spectrometry of ?-fetoprotein derived glycopeptide. Particularly, according to the AFP glycopeptide analysis method of the invention, fucosylation rate of the glycopeptide having the sequence composed of Val-Asn-Phe-Thr-Glu-Ile-Gln-Lys is analyzed to diagnose liver cancer in the early developmental grade. In particular, fucosylation rate is higher in the liver cancer patients than in other liver disease patients, so that the comparison of the fucosylation rate can be useful to diagnose or distinguish liver cancer from other liver diseases in the early HCC patients.
    Type: Grant
    Filed: April 27, 2017
    Date of Patent: June 30, 2020
    Assignee: KOREA BASIC SCIENCE INSTITUTE
    Inventors: Jong Shin Yoo, Kwang Hoe Kim, Jin Young Kim, Ju Yeon Lee
  • DIAGNOSTIC METHOD OF LIVER CANCER USING ALPHA-FETOPROTEIN DERIVED GLYCOPEPTIDES BY MASS SPECTROMETRY
    Publication number: 20200018759
    Abstract: The present invention relates to a diagnosis method of liver cancer using mass spectrometry of ?-fetoprotein derived glycopeptide. Particularly, according to the AFP glycopeptide analysis method of the invention, fucosylation rate of the glycopeptide having the sequence composed of Val-Asn-Phe-Thr-Glu-Ile-Gln-Lys is analyzed to diagnose liver cancer in the early developmental grade. In particular, fucosylation rate is higher in the liver cancer patients than in other liver disease patients, so that the comparison of the fucosylation rate can be useful to diagnose or distinguish liver cancer from other liver diseases in the early HCC patients.
    Type: Application
    Filed: April 27, 2017
    Publication date: January 16, 2020
    Applicant: KOREA BASIC SCIENCE INSTITUTE
    Inventors: Jong Shin Yoo, Kwang Hoe Kim, Jin Young Kim, Ju Yeon Lee